West Pharmaceutical Services, Inc.'s Q2 results highlight growth driven by GLP-1 drugs and high-value products. Click for WST ...

Brasada Capital Management, an investment management company, released its Q2 2025 investor letter. A copy of the letter can be downloaded here. This year’s financial markets have been highly volatile ...

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

West Pharmaceutical Services is expected to announce its second-quarter results later this month, with analysts projecting a marginal drop in its bottom line.

Key Points - Adjusted EPS was $1.84 in Q2 FY2025, beating the $1.51 estimate by 21.9%, and GAAP revenue exceeded expectations by $40.4 million. Proprietary Products sales rose 10.7%, driven by strong ...

West Pharmaceutical Services, Inc. (NYSE:WST) shares are surging Thursday after the injectable pharmaceutical packaging and ...

The S&P 500 gained 0.1% on Thursday, July 24, 2025, notching an all-time closing high for the fourth straight day following ...

West Pharmaceutical Services WST is scheduled to release second-quarter 2025 results on July 24, before the opening bell. In ...

West Pharmaceutical Services, Inc. (NYSE: WST) Q1 2025 Earnings Conference Call April 24, 2025 9:00 AM ET Company Participants John Sweeney - Vice President of Investor Relations Eric Green ...

West Pharmaceutical Services WST is scheduled to release first-quarter 2025 results on April 24, before the opening bell. In the last reported quarter, the company delivered an earnings beat of 4.00%.

West Pharmaceutical Services Inc.'s stock tumbled 33% Thursday, to lead S&P 500 decliners, after the manufacturer of injectable-pharmaceutical packaging and delivery systems offered guidance for ...